Plus   Neg

Dr. Reddy's Laboratories (RDY) Jumped After Court Ruling

A U.S. District Court ruled that Dr. Reddy's Laboratories (RDY) has not infringed on Indivior's patents for an opioid addiction treatment. Indivior plans to appeal the decision.

Dr. Reddy's Laboratories gapped up sharply Friday, but traded in a range throughout the session. Shares finished up by 2.48 at $34.67 on the highest volume of the year. The stock jumped to nearly a 1-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT